Reply to Li, Henry, and Nguyen

Mandana Khalili; David E. Kleiner; Wendy C. King; Richard K. Sterling; Marc G. Ghany; Raymond T. Chung; Atul K. Bhan; Philip Rosenthal; Mauricio Lisker-Melman; Rageshree Ramachandran; Anna S. Lok

doi:10.14309/ajg.0000000000001662

Reply to Li, Henry, and Nguyen

Mandana Khalili, David E. Kleiner, Wendy C. King, Richard K. Sterling, Marc G. Ghany, Raymond T. Chung, Atul K. Bhan, Philip Rosenthal, Mauricio Lisker-Melman, Rageshree Ramachandran, Anna S. Lok

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	688-689
Number of pages	2
Journal	American Journal of Gastroenterology
Volume	117
Issue number	4
DOIs	https://doi.org/10.14309/ajg.0000000000001662
State	Published - Apr 1 2022

Access to Document

10.14309/ajg.0000000000001662

Cite this

@article{2b26687b86fa4bbd876910ea6fa60580,

title = "Reply to Li, Henry, and Nguyen",

author = "Mandana Khalili and Kleiner, {David E.} and King, {Wendy C.} and Sterling, {Richard K.} and Ghany, {Marc G.} and Chung, {Raymond T.} and Bhan, {Atul K.} and Philip Rosenthal and Mauricio Lisker-Melman and Rageshree Ramachandran and Lok, {Anna S.}",

note = "Funding Information: Financial support: The HBRN was funded as a cooperative agreement between the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the following investigators: Lewis R. Roberts, MB, ChB, PhD (U01-DK082843); Anna Suk-Fong Lok, MD (U01-DK082863); Steven H. Belle, PhD, MScHyg (U01-DK082864); Kyong-Mi Chang, MD (U01-DK082866); Michael W. Fried, MD (U01-DK082867); Adrian M. Di Bisceglie, MD (U01-DK082871); William M. Lee, MD (U01-DK082872); Harry L. A. Janssen, MD, PhD (U01-DK082874); Daryl T-Y Lau, MD, MPH (U01-DK082919); Richard K. Sterling, MD, MSc (U01-DK082923); Steven-Huy B. Han, MD (U01-DK082927); Robert C. Carithers, MD (U01-DK082943); Mandana Khalili, MD (U01-DK082944); and Kathleen B. Schwarz, MD (U01-DK082916); an interagency agreement with NIDDK: Lilia M. Ganova-Raeva, PhD (A-DK-3002-001); and support from the intramural program, NIDDK, NIH: Marc G. Ghany, MD, and NCI, NIH: David E. Kleiner MD, PhD. Additional funding to support this study was provided to Kyong-Mi Chang, MD, the Immunology Center, (NIH/NIDDK Center of Molecular Studies in Digestive and Liver Diseases P30DK50306, NIH Public Health Service Research Grant M01-RR00040); Richard K. Sterling, MD, MSc (UL1TR000058, NCATS, National Center for Advancing Translational Sciences, NIH); Mandana Khalili, MD (CTSA Grant No. UL1TR000004); Michael W. Fried, MD (CTSA Grant No. UL1TR001111); Anna Suk-Fong Lok (CTSA Grant No. UL1RR024986 and U54TR001959); and Kathleen B. Schwarz, MD (CTSA Grant No. UL1TR000423). Additional support was provided by Gilead Sciences and Roche Molecular Systems by a CRADA through the NIDDK. M.K. was also partially supported by K24AA022523. Funding Information: Potential competing interests: M.K. is a recipient of a research grant (to her institution) from Gilead Sciences and Intercept Pharmaceuticals, and she has served as consultant for Gilead Sciences. Raymond Chung has research grants (to institution) from Gilead, AbbVie, BMS, Merck, Boehringer, Roche, Janssen, and from the MGH Research Scholars Program. P.R. has research support from Gilead Sciences, AbbVie, Merck, Arrowhead, and Retrophin and consults for Gilead, AbbVie, Retrophin, Albireo, Mirum, Audentes, and Dicerna. M.L.-M. serves on the speaker bureau for AbbVie, Gilead Sciences, and SimplySpeaking. R.K.S. has received research grants from Abbott, AbbVie, Gilead, and Roche and serves on the data safety and monitoring board for Pfizer and Baxter. A.S.L. has received research grant support (to the University of Michigan) from Bristol-Myers Squibb, Gilead, and TARGET and has served on advisory panels of Gilead and TARGET. W.C.K. has received funding from Abbott. M.G.G., A.K.B., R.R., and D.K. do not have any disclosures relevant to this project.",

year = "2022",

month = apr,

day = "1",

doi = "10.14309/ajg.0000000000001662",

language = "English",

volume = "117",

pages = "688--689",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

number = "4",

}

TY - JOUR

T1 - Reply to Li, Henry, and Nguyen

AU - Khalili, Mandana

AU - Kleiner, David E.

AU - King, Wendy C.

AU - Sterling, Richard K.

AU - Ghany, Marc G.

AU - Chung, Raymond T.

AU - Bhan, Atul K.

AU - Rosenthal, Philip

AU - Lisker-Melman, Mauricio

AU - Ramachandran, Rageshree

AU - Lok, Anna S.

N1 - Funding Information: Financial support: The HBRN was funded as a cooperative agreement between the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the following investigators: Lewis R. Roberts, MB, ChB, PhD (U01-DK082843); Anna Suk-Fong Lok, MD (U01-DK082863); Steven H. Belle, PhD, MScHyg (U01-DK082864); Kyong-Mi Chang, MD (U01-DK082866); Michael W. Fried, MD (U01-DK082867); Adrian M. Di Bisceglie, MD (U01-DK082871); William M. Lee, MD (U01-DK082872); Harry L. A. Janssen, MD, PhD (U01-DK082874); Daryl T-Y Lau, MD, MPH (U01-DK082919); Richard K. Sterling, MD, MSc (U01-DK082923); Steven-Huy B. Han, MD (U01-DK082927); Robert C. Carithers, MD (U01-DK082943); Mandana Khalili, MD (U01-DK082944); and Kathleen B. Schwarz, MD (U01-DK082916); an interagency agreement with NIDDK: Lilia M. Ganova-Raeva, PhD (A-DK-3002-001); and support from the intramural program, NIDDK, NIH: Marc G. Ghany, MD, and NCI, NIH: David E. Kleiner MD, PhD. Additional funding to support this study was provided to Kyong-Mi Chang, MD, the Immunology Center, (NIH/NIDDK Center of Molecular Studies in Digestive and Liver Diseases P30DK50306, NIH Public Health Service Research Grant M01-RR00040); Richard K. Sterling, MD, MSc (UL1TR000058, NCATS, National Center for Advancing Translational Sciences, NIH); Mandana Khalili, MD (CTSA Grant No. UL1TR000004); Michael W. Fried, MD (CTSA Grant No. UL1TR001111); Anna Suk-Fong Lok (CTSA Grant No. UL1RR024986 and U54TR001959); and Kathleen B. Schwarz, MD (CTSA Grant No. UL1TR000423). Additional support was provided by Gilead Sciences and Roche Molecular Systems by a CRADA through the NIDDK. M.K. was also partially supported by K24AA022523. Funding Information: Potential competing interests: M.K. is a recipient of a research grant (to her institution) from Gilead Sciences and Intercept Pharmaceuticals, and she has served as consultant for Gilead Sciences. Raymond Chung has research grants (to institution) from Gilead, AbbVie, BMS, Merck, Boehringer, Roche, Janssen, and from the MGH Research Scholars Program. P.R. has research support from Gilead Sciences, AbbVie, Merck, Arrowhead, and Retrophin and consults for Gilead, AbbVie, Retrophin, Albireo, Mirum, Audentes, and Dicerna. M.L.-M. serves on the speaker bureau for AbbVie, Gilead Sciences, and SimplySpeaking. R.K.S. has received research grants from Abbott, AbbVie, Gilead, and Roche and serves on the data safety and monitoring board for Pfizer and Baxter. A.S.L. has received research grant support (to the University of Michigan) from Bristol-Myers Squibb, Gilead, and TARGET and has served on advisory panels of Gilead and TARGET. W.C.K. has received funding from Abbott. M.G.G., A.K.B., R.R., and D.K. do not have any disclosures relevant to this project.

PY - 2022/4/1

Y1 - 2022/4/1

UR - http://www.scopus.com/inward/record.url?scp=85128159816&partnerID=8YFLogxK

U2 - 10.14309/ajg.0000000000001662

DO - 10.14309/ajg.0000000000001662

M3 - Letter

C2 - 35158369

AN - SCOPUS:85128159816

SN - 0002-9270

VL - 117

SP - 688

EP - 689

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

IS - 4

ER -

Reply to Li, Henry, and Nguyen

Access to Document

Other files and links

Cite this